CIRM Funded Clinical Trials

A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus

Disease Area:
Lupus, Systemic Lupus Erythematosus (SLE)
Investigator:
CIRM Grant:
CLIN2-16303 (Active)
Award Value:
$7,934,448.00
Trial Sponsor:
Fate Therapeutics, Inc.
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov